Multiple Sclerosis (MS) is an autoimmune disease characterized by demyelination in the central nervous system, leading to various clinical phenotypes and disease progressions. The global incidence of MS stands at a median of 35.9 cases per 100,000 people, with even lower rates in China, where it is considered a rare disease (Walton et al., 2020; … Leggi tutto SARS-CoV-2-Induced Transformation of Multiple Sclerosis into Tumefactive Demyelinating Lesions